Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (6): 1063-1068. doi: 10.19723/j.issn.1671-167X.2020.06.012

Previous Articles     Next Articles

Investigation of sleep disturbance and related factors in patients with primary Sjögren’s syndrome

Yi-fan WANG1,Zhen FAN2,Yao-bin CHENG1,Yue-bo JIN1,Yang HUO3,Jing HE1,△()   

  1. 1. Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China
    2. Department of Rheumatology and Immunology, Jinmen NO.1 People’s Hospital, Jingmen 448000, Hubei, China
    3. Department of Neurology, Peking University People’s Hospital, Beijing 100044, China
  • Received:2020-07-13 Online:2020-12-18 Published:2020-12-13
  • Contact: Jing HE E-mail:hejing1105@126.com
  • Supported by:
    National Natural Science Foundation of China(31870879);National Natural Science Foundation of China(81701607)

RICH HTML

 18   

PDF (PC)

234

Abstract:

Objective: To investigate the prevalence of sleep disorders and the relevant determinants in a cohort of primary Sj?gren’s syndrome (pSS) patients. Methods: One hundred and eighty-six pSS patients were included in the study, who were admitted to Peking University People’s Hospital and met the criteria of inclusion and exclusion. Sleep quality was assessed using the Pittsburgh sleep quality index(PSQI).Depression, anxiety were evaluated by patient health questionnaire (PHQ)-9,generalized anxiety disorder(GAD)-7, respectively. The demographic and clinical data were also recorded.Disease activity and damage were evaluated with the European League Against Rheumatism Sj?gren’s syndrome disease activity index (ESSDAI). According to the PSQI score>7, the pSS patients were divided into 152 cases of sleep disorder group and 34 cases of normal sleep group. Mann-Whitney U test, Chi-square test or Fisher’s exact test, independent samples t test, Spearman correlation analysis and Logistic regression were used for statistical analysis. Results: The prevalence of sleep disturbance (PSQI>7) was 81.7% (152 / 186) in the pSS patients, and 52.7% (98/186) had moderate or severe sleep disorders (PSQI≥11). The mean PSQI score of sleep disordered group was (12.29±3.30), while the normal sleep group PSQI score was (5.50±1.20). The PSQI score, PHQ-9 score and GAD-7 score in the sleep-disordered group were significantly higher than those in the normal sleep group (P=0.000, 0.035, 0.031). The PSQI score in the sleep disordered group were significantly higher than those in the normal sleep group in seven aspects: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disorders, hypnotic drug use and daytime dysfunction. All of them had statistical significance. According to the results of Spearman correlation analysis, PSQI had significantly positive correlation with course of disease, anxiety, depression score (r=0.151, 0.240, 0.421, P<0.05), but negatively correlated with C3,C4 (r=-0.021, -0.235, P<0.05). Logistic analysis identified the course of disease(OR=2.809, 95%CI: 1.21-6.52)and PHQ-9 score(OR=1.422, 95%CI: 1.04-1.94)as predictors of sleep disorders. Conclusion: The incidence of sleep disorder in the pSS patients was higher, which was closely related to the course of disease, anxiety, depression and other factors. It is critical to assess and manage comprehensively the disease.

Key words: Sj?gren's syndrome, Sleep disorders, Anxiety, Depression, Risk factors

CLC Number: 

  • R783.2

Table 1

Comparison of general data between the two groups of pSS patients"

Items Sleep-disordered group Normal sleep group P value
Total cases, n 152 34
Female/% 96.1 100 0.538
Age/years, M (P25, P75) 59.5 (54.25,65) 64.0 (54.5,67) 0.456
Disease duration/ years, M (P25, P75) 7.5 (3,7.5) 3 (3,7.5) 0.024*
BMI/(kg/m2), M (P25, P75) 21.8 (20.1,23) 23.4 (22,25.3) 0.061

Table 2

Comparison of laboratory features between the two groups of pSS patients"

Items Sleep-disordered group Normal sleep group P value
WBC/(×109/L), M (P25, P75) 5.0 (4.6,5.4) 4.9 (4.5,5.4) 0.351
HGB/(g/L), x-±s 127±19.9 130±11.8 0.366
PLT/(×1012/L), M (P25, P75) 194 (180,208) 196 (168,227) 0.846
ESR/(mm/h), M (P25, P75) 21.2 (17.0,25.4) 21.7 (12.5,30.8) 0.727
CRP/(mg/L), M (P25, P75) 5.0 (0.9,9.0) 1.6 (0.3,3.5) 0.016*
α-fodrin/(RU/mL), M (P25, P75) 18.1 (13.3,23.1) 15.7 (5.9,25.5) 0.082
RF /(IU/mL), M (P25, P75) 171 (13.8,329) 101 (19.0,184) 0.144
IgA/(g/L), x-±s 3.8±4.1 2.9±1.7 0.213
IgG/(g/L), M (P25, P75) 14.6 (13.1,16.1) 16.6 (14.1,19.2) 0.211
IgM/(g/L), M (P25, P75) 1.3 (1.1,1.5) 1.2 (0.9,1.6) 0.714
C3/(g/L), x-±s 0.9±0.2 0.9±0.1 0.925
C4/(g/L), x-±s 0.2±0.1 0.3±0.3 0.171
γ globulin/%, M (P25, P75) 20.6 (19.1,22.1) 21.7 (19.1,24.3) 0.103
RBP/(mg/L), x-±s 1.12±3.1 0.3±0.1 0.085
β2-MG/(μg/L), M (P25, P75) 695 (63.0,1327) 262 (87.8,437) 0.781
NAG(U/L), M (P25, P75) 10.2 (8.7,11.7) 14.8 (9.0,20.5) 0.989

Table 3

The PSQI score of pSS patients of sleep-disordered group and normal sleep group"

Items Sleep-disordered group Normal sleep group P value
Total cases, n 152 34
Subjective sleep quality, M (P25, P75) 1 (1,2) 1 (0,1) <0.001*
Sleep latency, M (P25, P75) 2 (2,3) 1 (1,1) <0.001*
Sleep duration, M (P25, P75) 1.5 (1,2) 1 (0,1) 0.004*
Sleep efficiency, M (P25, P75) 3 (2,3) 1 (0,1) <0.001*
Sleep disturbance, M (P25, P75) 1 (1,1) 1 (1,1) 0.027*
Hypnotic drug use, M (P25, P75) 1 (1,2) 1 (0,1) <0.001*
Daytime dysfunction, M (P25, P75) 2 (2,3) 1 (1,2) 0.001*
PSQI global, x-±s 12.29±3.30 5.50±1.20 <0.001*

Table 4

The PHQ-9 score and GAD-7 score of pSS patients of two groups"

Items Sleep-disordered group Normal sleep group P value
Total cases, n 152 34
PHQ-9, M (P25, P75) 6 (4,8) 4 (2,5) 0.035*
GAD-7, M (P25, P75) 3.5 (2,6) 2 (1,4) 0.031*
[1] Mariette X, Criswell LA. Primary Sjögren’s syndrome[J]. N Engl J Med, 2018,378(10):931-939.
pmid: 29514034
[2] Cafaro G, Croia C, Argyropoulou Od, et al. One year in review 2019: Sjögren’s syndrome[J]. Clin Exp Rheumatol, 2019, 37, 118(3):3-15.
[3] Tsukamoto M, Suzuki K, Takeuchi T. Ten-year observation of patients with primary Sjögren’s syndrome: Initial presenting characteristics and the associated outcomes[J]. Int J Rheum Dis, 2019,22(5):929-933.
doi: 10.1111/1756-185X.13464 pmid: 30588773
[4] Shen L, He J, Kramer JM, et al. Sjögren’s syndrome: animal models, etiology, pathogenesis, clinical subtypes, and diagnosis[J]. J Immunol Res, 2019, 5(2019-05-20)[2020-04-10]. https://pubmed.ncbi.nlm.nih.gov/31236421.
[5] Cui Y, Xia L, Li L, et al. Anxiety and depression in primary Sjögren’s syndrome: a cross-sectional study[J]. BMC Psychiatry, 2018,18(1):131.
doi: 10.1186/s12888-018-1715-x pmid: 29769121
[6] Milin M, Cornec D, Chastaing M, et al. Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjögren’s syndrome[J]. Joint Bone Spine, 2016,83(6):681-685.
doi: 10.1016/j.jbspin.2015.10.005 pmid: 26774177
[7] Priori R, Minniti A, Antonazzo B, et al. Sleep quality in patients with primary Sjögren’s syndrome[J]. Clinical and Experimental Rheumatology, 2016,34(3):373-379.
pmid: 27087620
[8] Tishler M, Barak Y, Paran D, et al. Sleep disturbances, fibro-myalgia and primary Sjögren’s syndrome[J]. Clin Exp Rheumatol, 1997,15(1):71-74.
pmid: 9093776
[9] 中华医学会风湿病学分会. 干燥综合征诊断及治疗指南[J]. 中华风湿病学杂志, 2010,14(11):766-768.
[10] Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis[J]. Ann Rheum Dis, 2015,74(11):1983-1989.
doi: 10.1136/annrheumdis-2014-205375 pmid: 24938285
[11] 李晏, 张胜利, 黄烽. 强直性脊柱炎患者睡眠质量及相关因素分析[J]. 中华风湿病学杂志, 2012,16(4):25l-254.
[12] Lee YC, Chibnik LB, Lu B, et al. The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study[J]. Arthritis Res Ther, 2009,11(5):160.
[13] Palagini L, Tani C, Mauri M, et al. Sleep disorders and systemic lupus erythematosus[J]. Lupus, 2014,23(2):115-123.
pmid: 24421291
[14] Mustafa M, Bawazir Y, Merdad L, et al. Frequency of sleep disorders in patients with rheumatoid arthritis[J]. Open Access Rheumatol, 2019,11:163-171.
doi: 10.2147/OARRR.S201556 pmid: 31308768
[15] Gudbjornsson B, Broman JE, Hetta J, et al. Sleep disturbances in patients with primary Sjögren’s syndrome[J]. Br J Rheumatol, 1993,32(12):1072-1076.
pmid: 8252317
[16] Segal BM, Pogatchnik B, Henn L, et al. Pain severity and neuropathic pain symptoms in primary Sjögren’s syndrome: A comparison study of seropositive and seronegative Sjögren’s syndrome patients[J]. Arthritis Care Res(Hoboken), 2013,65(8):1291-1298.
[17] Watson NF, Badr MS, Belenky G, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the american academy of sleep medicine and sleep research society[J]. Sleep, 2015,11(6):591-592.
[18] Usmani ZA, Hlavac M, Rischmueller M, et al. Sleep disordered breathing in patients with primary Sjögren’s syndrome: A group controlled study[J]. Sleep Medicine, 2012,13(8):1066-1070.
doi: 10.1016/j.sleep.2012.06.010 pmid: 22841036
[19] Abad VC, Sarinas PS, Guilleminault C. Sleep and rheumatologic disorders[J]. Sleep Med Rev, 2008,12(3):211-228.
[20] Walker J, Gordon T, Lester S, et al. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren’s syndrome[J]. J Rheumatol, 2003,30(11):2406-2412.
pmid: 14677185
[21] Hackett KL, Gotts ZM, Ellis J, et al. An investigation into the prevalence of sleep disturbances in primary Sjögren’s syndrome: a systematic review of the literature[J]. Rheumatology, 2017,56(4):570-580.
doi: 10.1093/rheumatology/kew443 pmid: 28013207
[22] Theander L, Strombeck B, Mandl T, et al. Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjögren’s syndrome?[J]. Rheumatology, 2010,49(6):1177-1183.
doi: 10.1093/rheumatology/keq023 pmid: 20308122
[23] Ayaki M, Kawashima M, Negishi K, et al. Sleep and mood disorders in dry eye disease and allied irritating ocular diseases[J]. Sci Rep, 2016,6:22480.
doi: 10.1038/srep22480 pmid: 26927330
[24] Julich M, Budweiser S, Thoden J, et al. Sleep apnea in Sjögren’s syndrome potentially influences the EULAR Sjögren’s syndrome patient reported index[J]. Mod Rheumatol, 2019,29(3):563-565.
doi: 10.1080/14397595.2018.1467526 pmid: 29669457
[25] Hilditch CJ, McEvoy RD, George KE, et al. Upper airway surface tension but not upper airway collapsibility is elevated in primary Sjögren’s syndrome[J]. Sleep, 2008,31(3):367-374.
doi: 10.1093/sleep/31.3.367 pmid: 18363313
[26] Chung SW, Hur J, Ha YJ, et al. Impact of sleep quality on clinical features of primary Sjögren’s syndrome[J]. Korean J Intern Med, 2019,34(5):1154-1164.
doi: 10.3904/kjim.2017.158 pmid: 29458245
[27] Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk[J]. J Am Coll Cardiol, 2004,43(4):678-683.
doi: 10.1016/j.jacc.2003.07.050 pmid: 14975482
[28] Emami Zeydi A, Jannati Y, Darvishi Khezri H, et al. Sleep quality and its correlation with serum C-reactive protein level in hemodialysis patients[J]. Saudi J Kidney Dis Transpl, 2014,25(4):750-755.
doi: 10.4103/1319-2442.134962 pmid: 24969183
[29] Ho KKN, Simic M, Smastuen MC, et al. The association between insomnia, C-reactive protein, and chronic low back pain: cross-sectional analysis of the HUNT study, Norway[J]. Scand J Pain, 2019,19(4):765-777.
doi: 10.1515/sjpain-2019-0033
[30] Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation[J]. Biol Psychiatry, 2016,80(1):40-52.
doi: 10.1016/j.biopsych.2015.05.014 pmid: 26140821
[31] Ranjbaran Z, Keefer L, Stepanski E, et al. The relevance of sleep abnormalities to chronic inflammatory conditions[J]. Inflamm Res, 2007,56(2):51-57.
pmid: 17431741
[32] Irwin MR, Wang M, Campomayor CO, et al. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation[J]. Arch Intern Med, 2006,166(16):1756-1762.
doi: 10.1001/archinte.166.16.1756 pmid: 16983055
[33] Bollinger T, Bollinger A, Skrum L, et al. Sleep-dependent activity of T cells and regulatory T cells[J]. Clin Exp Immunol, 2009,155(2):231-238.
doi: 10.1111/j.1365-2249.2008.03822.x pmid: 19040608
[34] Tripp NH, Tarn J, Natasari A, et al. Fatigue in primary Sjögren’s syndrome is associated with lower levels of proinflammatory cytokines[J]. Rmd Open, 2016,2(2):e000282.
doi: 10.1136/rmdopen-2016-000282 pmid: 27493792
[1] SU Jun-qi,SONG Yang,XIE Shang. Analysis of etiological characteristics and establishment of prediction model of postoperative infections in patients undergoing oral squamous cell carcinoma surgery with free flap reconstruction [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 68-76.
[2] Hao XU,Guo-dong ZHANG,Guang-pu FAN,Yu CHEN. Preoperative plasma predictive factors of new-onset atrial fibrillation after coronary artery bypass graft surgery: A propensity score matching study [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1139-1143.
[3] Zhan-yue NIU,Yan XUE,Jing ZHANG,He-jun ZHANG,Shi-gang DING. Analysis of endoscopic and pathological features of gastric adenomatous polyps and risk factors for canceration [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1122-1127.
[4] Jing-xian ZHU,Sheng-nan LU,Yan-fang JIANG,Ling JIANG,Jian-quan WANG. Influencing factors of preoperative pulmonary function in elderly patients undergoing rotator cuff surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 902-906.
[5] WANG Jia-wen,LIU Jing-chao,MENG Ling-feng,ZHANG Wei,LIU Xiao-dong,ZHANG Yao-guang. Quality of life and related factors in patients with interstitial cystitis/bladder pain syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 653-658.
[6] SUN Zheng-hui,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,YAN Ye,LIU Cheng,MA Lu-lin. Risk factors of renal sinus invasion in clinical T1 renal cell carcinoma patients undergoing nephrectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 659-664.
[7] FAN Li-shi,GAO Min,Edwin B. FISHER,SUN Xin-ying. Factors associated with quality of life in 747 patients with type 2 diabetes in Tongzhou District and Shunyi District of Beijing [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 523-529.
[8] ZHOU Bo-lin,LI Wei-shi,SUN Chui-guo,QI Qiang,CHEN Zhong-qiang,ZENG Yan. Risk factors for multiple debridements of the patients with deep incisional surgical site infection after spinal surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 286-292.
[9] XIA Fang-fang,LU Fu-ai,LV Hui-min,YANG Guo-an,LIU Yuan. Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 266-272.
[10] LIU Xiao-qiang,YANG Yang,ZHOU Jian-feng,LIU Jian-zhang,TAN Jian-guo. Blood pressure and heart rate changes of 640 single dental implant surgeries [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 390-395.
[11] HOU Guo-jin,ZHOU Fang,TIAN Yun,JI Hong-quan,ZHANG Zhi-shan,GUO Yan,LV Yang,YANG Zhong-wei,ZHANG Ya-wen. Risk factors of recurrent kyphosis in thoracolumbar burst fracture patients treated by short segmental pedicle screw fixation [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 167-174.
[12] MENG Zhao-ting,MU Dong-liang. Impact of oliguria during lung surgery on postoperative acute kidney injury [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 188-194.
[13] WANG Ying-chun,HUANG Yong-hui,CHANG Hong,YAO Wei,YAN Xiu-e,LI Ke,ZHANG Yao-peng,ZHENG Wei. Characteristics of benign and malignant lesions of ampullary polyps and the accuracy of forceps biopsy [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 204-209.
[14] Jia-li CHEN,Yue-bo JIN,Yi-fan WANG,Xiao-ying ZHANG,Jing LI,Hai-hong YAO,Jing HE,Chun LI. Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1040-1047.
[15] Yan GENG,Zhi-bo SONG,Xiao-hui ZHANG,Xue-rong DENG,Yu WANG,Zhuo-li ZHANG. Depression and anxiety in patients with psoriatic arthritis: Prevalence and associated factors [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1048-1055.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 505 -515 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .
[10] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 516 -520 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd